The outbreak of the SARS-CoV-2 pandemic has made the general public aware of the breakthrough technologies which were developed in recent years for state-of-the-art biosensing, and terms such as clinical specificity and sensitivity are now widely understood. The need for reliable point-of-care diagnostic systems during the last few years has been crucial.